See how funds are faring during market turmoil with deal-level cash-on-cash returns, exit proceeds, check sizes, and performance metrics for 1,500+ biopharma investors covering $80B+ in global venture investment since January 2018.
Analyze portfolio concentration and returns distribution. Which funds returned the fund with a single investment? Which funds hit consistent triples and doubles?
Analyze fund strategy and competitiveness with valuations and check size data for hundreds of rounds.
Breakdown fund portfolios by therapeutic area, development stage, location, and deal series.
Details on investment activity since January 2018, including therapeutic area, stage and co-investors.
Biopharma-focused M&A, IPO and venture comps covering $55B+ in venture investment and hundreds of exits going back to January 2018.